Skip to main content
iNtRON Biotechnology, Inc. logo

iNtRON Biotechnology, Inc. — Investor Relations & Filings

Ticker · 048530 ISIN · KR7048530000 KO Manufacturing
Open in API
Filings indexed 268 across all filing types
Latest filing 2021-09-02 Transaction in Own Shar…
Country KR South Korea
Listing KO 048530

About iNtRON Biotechnology, Inc.

https://intronbio.com:6001

iNtRON Biotechnology, Inc. is a biotechnology company specializing in solutions for infectious diseases. Its core activities are centered on three main pillars: bio-new drugs, molecular diagnostics, and molecular biology reagents. The company's therapeutic pipeline focuses on developing novel treatments for drug-resistant super-bacteria, creating antibiotic alternatives and other bio-active agents to address the challenge of antimicrobial resistance (AMR). In its diagnostics division, iNtRON develops and manufactures detection kits and assays, primarily based on real-time PCR technology, for the rapid identification of infectious organisms. The company also provides a range of molecular reagents for research and has commercialized antibiotic alternative products for the animal health market.

Recent filings

Filing Released Lang Actions
신탁계약해지결과보고서
Transaction in Own Shares Classification · 100% confidence The document is a '신탁계약해지결과보고서' (Report on the Termination of a Trust Agreement) filed with the Financial Supervisory Service (FSS) in South Korea. This document details the termination of a stock repurchase trust agreement and the resulting status of the company's treasury shares. In the context of corporate filings, reports regarding the acquisition, disposal, or termination of trust agreements related to a company's own shares are classified as 'Transaction in Own Shares' (POS).
2021-09-02 Korean
증권발행결과(자율공시)
Share Issue/Capital Change Classification · 100% confidence The document is a formal announcement regarding the results of a securities issuance (specifically a private placement of convertible bonds). It details the issuance amount, payment date, and the nature of the securities. This falls under the category of capital and financing updates, specifically related to the issuance of debt/equity instruments.
2021-09-01 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a formal 'Major Report' (주요사항보고서) filed with the Korea Exchange regarding the decision to issue convertible bonds (전환사채권 발행결정). It details the terms of the issuance, including interest rates, conversion prices, call/put options, and the list of investors. This falls under the category of capital and financing updates.
2021-08-31 Korean
반기보고서 (2021.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-annual Report) for the company 'iNtRON Biotechnology, Inc.' covering the period from January 1, 2021, to June 30, 2021. It contains detailed financial information, business operations, management discussions, and corporate governance details, which are characteristic of an interim financial report. It is not a mere announcement or certification, as it provides substantive financial data and business analysis. H1 2021
2021-08-13 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a regulatory filing required when an entity's shareholding in a company crosses certain thresholds (typically 5%). The text details the reporting entity (Mirae Asset Global Investments), the target company (Intron Biotechnology), the number of shares held, and a chronological log of transactions (buy/sell/ETF adjustments). This falls under the 'Major Shareholding Notification' category.
2021-07-01 Korean
신탁계약해지결과보고서
Transaction in Own Shares Classification · 100% confidence The document is a '신탁계약해지결과보고서' (Trust Contract Termination Result Report) filed with the Financial Supervisory Service (FSS) in South Korea. It details the termination of a trust contract related to treasury shares (자사주). According to the provided filing definitions, reports regarding the company's own share transactions, including the termination of trust contracts for share buybacks, fall under the 'Transaction in Own Shares' category (POS).
2021-06-29 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.